» Articles » PMID: 1421344

In Vitro Activity of Meropenem and Imipenem Against Mycobacteria: Development of a Daily Antibiotic Dosing Schedule

Overview
Journal Tuber Lung Dis
Specialty Pulmonary Medicine
Date 1992 Jun 1
PMID 1421344
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The activity of two carbapenem antibiotics, meropenem and imipenem, against Mycobacterium species was assessed by means of the Bactec 460 radiometric apparatus. This system allowed a result to be read in 4-10 days. The instability of imipenem, particularly, in the test system necessitated the development of a regimen of daily addition of antibiotic to permit a more accurate assessment of antibiotic activity to be made. When antibiotic-containing media are incubated for long periods, as is the case when determining antimycobacterial activity, the stability of test antibiotics is an important factor that must be considered.

Citing Articles

Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation.

Boorgula G, Gumbo T, Singh S, McShane P, Philley J, Srivastava S Tuberculosis (Edinb). 2024; 147:102519.

PMID: 38754247 PMC: 11345947. DOI: 10.1016/j.tube.2024.102519.


It takes two to tango! Stability of drugs affecting efficacy against Mycobacterium abscessus.

Singh S, Srivastava S Int J Antimicrob Agents. 2023; 63(2):107060.

PMID: 38097052 PMC: 11334999. DOI: 10.1016/j.ijantimicag.2023.107060.


Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen.

Singh S, Gumbo T, Alffenaar J, Boorgula G, Shankar P, Thomas T Int J Antimicrob Agents. 2023; 62(6):106968.

PMID: 37726063 PMC: 10850916. DOI: 10.1016/j.ijantimicag.2023.106968.


"Upcycling" known molecules and targets for drug-resistant TB.

Roubert C, Fontaine E, Upton A Front Cell Infect Microbiol. 2022; 12:1029044.

PMID: 36275029 PMC: 9582839. DOI: 10.3389/fcimb.2022.1029044.


Are the Newer Carbapenems of Any Value against Tuberculosis.

Gonzalo X, Drobniewski F Antibiotics (Basel). 2022; 11(8).

PMID: 36009939 PMC: 9404707. DOI: 10.3390/antibiotics11081070.